Lynn Kirkpatrick

Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling

Nathan T. Ihle, Ryan Williams, Sherry Chow et al. · Molecular Cancer Therapeutics · 2004 · 311 citations · Full text

Hypoxia inducible factor-1α as a cancer drug target

Garth Powis, Lynn Kirkpatrick · Molecular Cancer Therapeutics · 2004 · 310 citations · Full text

Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha.

Sarah J. Welsh, Ryan Williams, Lynn Kirkpatrick et al. · PubMed · 2004 · 281 citations

Hypoxia-induced Hif-1alpha Levels, Antitumor Activity, Chemoprevention Strategy +20

Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1α

Sarah J. Welsh, Ryan Williams, Lynn Kirkpatrick et al. · Molecular Cancer Therapeutics · 2004 · 242 citations

Hypoxia-induced Hif-1α Levels, Antitumor Activity, Cell Death +19

Dynamic Contrast-Enhanced and Diffusion MRI Show Rapid and Dramatic Changes in Tumor Microenvironment in Response to Inhibition of HIF-1α Using PX-478

Bénédicte F. Jordan, Matthew Runquist, Natarajan Raghunand et al. · Neoplasia · 2005 · 128 citations · Full text